Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge

Non-critical Emergency Room Patients Receiving Lortab Medication or Prescription During Their Emergency Room Visit Clinical Trial

Official title:

Video Assisted Informed Consent for Lortab to Improve Patient Satisfaction and Knowledge: A Randomized Control Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01374295
• Other study ID #: 2981
• Secondary ID: Lortab
• Status: Completed
• Phase: N/A
• First received: June 7, 2011
• Last updated: March 21, 2014
• Start date: March 2011
• Est. completion date: January 2012

Study information

• Verified date: June 2011
• Source: Albany Medical College
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: AMC Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

In order to compare two different forms of patient education; patients who receive Lortab medication or prescription during their ED visit are randomized to receive either standard patient education (from healthcare provider) or video assisted education. After education, patient completes a survey, estimated to take 5 minutes to complete.

Description:

The purpose of this study is to compare different methods of teaching patients about their prescription medicines. It is possible that certain teaching methods are better than others at educating patients.

Patients who receive Lortab medication or prescription during their ED visit and agree to the study are randomized to receive either standard patient education (from healthcare provider) or watch a 3 minute video. After the medication teaching has been provided the patient is given the medicine and a asked to complete a ten-question survey. This takes approximately five minutes and asks the patient to rate the quality of the information received.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: January 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• non-critical emergency room patients being prescribed Lortab

• age 18 year or older

Exclusion Criteria:

• emergency room patients not receiving Lortab as their first prescribed medication

• age less than 18 years

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver)

Related Conditions & MeSH terms

• Emergencies
• Non-critical Emergency Room Patients Receiving Lortab Medication or Prescription During Their Emergency Room Visit

Intervention

Other:
• video
watch a 3 minute video
• standard education
Receives standard verbal education from healthcare provider

Locations

Country	Name	City	State
United States	Albany Medical Center	Albany	New York

Sponsors (1)

Lead Sponsor	Collaborator
Albany Medical College

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	patient satisfaction and knowledge	comparison of patient completed survey following education via standard format or 3 minute video	survey is completed immediately after education, estimated time to complete survey is 5 minutes	No